Executive Search Success Story: Scaling Commercial Leadership for a Cardiovascular Device Manufacturer

How JRG Partners executed a highly confidential, multi-role North American executive search strategy that equipped a rapidly growing cardiovascular medical device manufacturer with the specialized commercial, clinical, and regulatory leadership required to accelerate growth, drive physician adoption, and navigate complex international compliance frameworks.

The Challenge

A rapidly growing cardiovascular medical device manufacturer was experiencing significant expansion driven by increased demand for minimally invasive cardiac technologies, strategic product launches, and geographic market growth. While revenue continued to increase, executive leadership identified several critical, interlocking challenges that threatened to slow their expansion velocity:

• Growing competition from major, established cardiovascular device manufacturers
• Regulatory pressures associated with strict FDA and international compliance requirements
• High-stakes product-commercialization demands for newly approved technologies
• The need for aggressive sales-force expansion across key healthcare markets
• Pressing succession concerns among senior leadership
• An acute need for executives capable of accelerating growth while maintaining rigorous quality and compliance standards
• Increasing demand for physician engagement and formalized clinical-education initiatives

The Board of Directors and CEO determined that multiple strategic leadership hires would be required to support the company’s next phase of growth. The confidential mandate covered a Chief Commercial Officer, VP Sales, VP Marketing, VP Clinical Affairs, VP Regulatory Affairs, Director of Market Access, and Regional Sales Leadership executives. The company required a search partner with deep industry expertise, access to passive talent, and a proven ability to recruit leaders capable of driving growth in a highly regulated healthcare environment.

Why They Chose JRG Partners

Deep Cardiovascular Device Industry Expertise

Unlike generalist recruiting firms, JRG Partners maintains dedicated practices focused explicitly on medical devices, cardiovascular technologies, life sciences, healthcare leadership, clinical affairs, and commercial operations. Our consultants bring an intimate operational understanding of physician adoption, regulatory compliance, reimbursement strategy, and commercialization execution.

Access to Passive Medical Device Leaders

Many of the strongest cardiovascular device executives are fully employed and not actively pursuing new opportunities on the open market. JRG Partners leveraged extensive industry relationships, proprietary market intelligence, and targeted research to identify and attract proven leaders from leading cardiovascular device manufacturers and healthcare technology organizations.

Confidential Search Execution

Because several leadership searches involved delicate succession planning and organizational restructuring, discretion was mandatory. JRG Partners conducted highly confidential searches that successfully protected the company’s market position and internal stability throughout the transition.

True Nationwide Reach

Securing world-class commercial and clinical direction required a comprehensive search across North America’s primary medical innovation clusters. JRG Partners successfully identified and engaged top medical device executives distributed across major metropolitan markets in the United States.

Our Executive Search Strategy

Phase 1 — Leadership & Strategic Assessment

Our consultants worked closely with the CEO, Board members, and HR leadership to thoroughly assess commercial-growth objectives, leadership-capability gaps, regulatory requirements, product-launch priorities, clinical-strategy initiatives, market-expansion goals, and cultural-alignment requirements. Rather than recruiting against existing, static job descriptions, we developed leadership profiles dynamically aligned with the company’s long-term strategic vision.

Phase 2 — Cardiovascular Talent Mapping

JRG Partners conducted an extensive market-mapping initiative covering cardiovascular device manufacturers, electrophysiology companies, structural heart device organizations, interventional cardiology businesses, diagnostic device companies, healthcare technology providers, and private equity-backed medical device firms. More than 450 executive profiles were systematically identified and evaluated across North America.

Phase 3 — Targeted Executive Engagement

Using a research-driven, discreet outreach framework, our consultants targeted leaders with demonstrated success in cardiovascular device commercialization, physician relationship development, clinical affairs leadership, regulatory strategy, product-launch execution, market-access expansion, and revenue-growth acceleration. Only candidates demonstrating measurable business impact and leadership excellence advanced.

Phase 4 — Rigorous Evaluation & Selection

Each finalist underwent a comprehensive evaluation covering strategic leadership capability, medical device industry expertise, commercial-execution success, team-building effectiveness, clinical and regulatory knowledge, change-management experience, cultural alignment, and long-term retention potential.

Key Outcomes

• 450+ targeted cardiovascular, electrophysiology, and structural heart executive profiles mapped across primary North American medical device corridors.
• Successfully placed and integrated seven core leaders spanning sales, marketing, clinical affairs, regulatory strategy, and market access within 12 months.
• Expanded physician adoption and market penetration by installing sales and marketing leadership built for high-stakes clinical deployment.
• De-risked global regulatory pathways and accelerated launch timelines via incoming regulatory executives fluent in FDA compliance.
• Protected corporate morale and preserved internal stability during sensitive leadership upgrades by executing strict, confidential executive searches.
• Restored Board and investor confidence by resolving key succession risks and providing a scalable management infrastructure ready for long-term category expansion.